While CYP+DOX effectively reduces tumor growth on its own, combining these drugs with a choline-enriched diet may offer additional benefits in managing tumor progression, suggesting a multifaceted approach to cancer therapy in which dietary modifications could complement pharmacological treatments to enhance overall treatment efficacy and potentially mitigate side effects. The gene discussed is PPIG; the disease is neoplasm.